This is an equity-research query on MCX (Multi Commodity Exchange of India Ltd, NSE: MCX). There is no single “official” target price; different brokerages publish their own.

Based on the latest publicly available reports (up to November 2025), recent 12‑month target prices for MCX include (examples):

- Axis Capital – Buy, target price ₹12,500 (in.investing.com)

- UBS – Raised target price to ₹12,000 (businesstoday.in)

- Motilal Oswal (MOFSL) – Neutral, target price around ₹10,700 (businesstoday.in)

- HDFC Institutional Equities – Buy, target price around ₹10,500 (businesstoday.in)

- ICICI Securities – Add, target price around ₹8,800 (older, June 2025 report) (businesstoday.in)

Indicatively, current published broker targets span roughly ₹8,800–₹12,500 per share, with many newer reports in the ₹10,500–₹12,500 band. These are research-house opinions, can change frequently, and should not be treated as personalized investment advice.

For the most relevant target for you, you should review the latest full research reports and consider your risk profile, horizon, and diversification before acting.

If you have any further queries, please connect with us on 022-6290-10141 (Timings : 09.00 AM to 05.00 PM) or you can email us on info@cniinfoxchange.com